Added to YB: 2025-04-29
Pitch date: 2025-04-25
ICLR [neutral]
ICON Public Limited Company
-32.73%
current return
Author Info
DeepValue Capital is investing in quality turnaround companies. Sign up for the newsletter.
Company Info
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.
Market Cap
$6.8B
Pitch Price
$146.29
Price Target
486.00 (+394%)
Dividend
N/A
EV/EBITDA
6.30
P/E
11.86
EV/Sales
1.22
Sector
Life Sciences Tools and Services
Category
growth
Quietly Printing $1B While Biotech Burns - ICON Public Limited Company
ICLR (more research needed): CRO down 60% since July despite $25B backlog, $1.1B FCF. Pharma facing $200B patent cliff by 2030 driving R&D spend. Bull case: 110% upside (28% CAGR) at 18x FCF in 3yrs. Risks: lawsuit credibility issues, competitive positioning, accounting trust. No position yet, needs more research.
Read full article (3 min)